Drug Trial Radar · NCT03921528
An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy
Last checked: Nov 20, 2026Latest source record: Dec 2, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
58
Actual
Start
Apr 22, 2019
Primary completion
Jan 19, 2021
Study completion Feb 28, 2024
Sponsor
- Lead sponsor
- Scholar Rock, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 19, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The TOPAZ study will assess the safety and efficacy of SRK-015 in later-onset Spinal Muscular Atrophy (SMA Type 2 and Type 3) in pediatric and adult patients.
Conditions
- Spinal Muscular Atrophy
- Spinal Muscular Atrophy Type 3
- Spinal Muscular Atrophy Type 2
- SMA
- Neuromuscular Diseases
- Muscular Atrophy
- Atrophy
- Muscular Atrophy, Spinal
- Neuromuscular Manifestations
Interventions
SRK-015Biological
SRK-015 is a fully human anti-proMyostatin monoclonal antibody (mAb) of the immunoglobulin G4 (IgG4)/lambda isotype that binds to human pro/latent myostatin with high affinity. SRK-015 will be administered every 4 weeks by intravenous infusion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cohort 1: Change From Baseline in the Revised Hammersmith Scale (RHS) Total Score at Day 364 (Visit 15) [Month 12]Time frame: Baseline up to 12 months
- Cohort 2 and Cohort 3: Change From Baseline in Hammersmith Functional Motor Scale Expanded (HFMSE) Total Score at Day 364 (Visit 15) [Month 12]Time frame: Baseline up to 12 months
Locations
16 sites in 4 countries. Site status is shown where the registry gives one.
Phoenix Children's Hospital
Phoenix, Arizona
Stanford University
Palo Alto, California
Children's Hospital Colorado
Aurora, Colorado
The Johns Hopkins University
Baltimore, Maryland
Boston Children's Hospital
Boston, Massachusetts
Helen DeVos Children's Hospital
Grand Rapids, Michigan
Columbia University
New York, New York
Wake Forest School of Medicine
Winston-Salem, North Carolina
Oregon Health & Science University
Portland, Oregon
Childrens Medical Center Dallas
Dallas, Texas
Children's Hospital of The King's Daughters
Norfolk, Virginia
ASST Grande Ospedale Metropolitano Niguarda
Milan, Italy
Centro Clinico Nemo Pediatrico Policlinico A. Gemelli-Università Cattolica Sacro Cuore
Roma, Italy
Universitair Medisch Centrum Utrecht
Utrecht, Netherlands
Hospital Sant Joan de Déu
Barcelona, Spain
Hospital Universitari i Politecnic La Fe
Valencia, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.